NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 28 filers reported holding NIVALIS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,000 | -33.3% | 2,700 | -32.5% | 0.00% | – |
| Q4 2016 | $9,000 | -72.7% | 4,000 | 0.0% | 0.00% | – |
| Q3 2016 | $33,000 | +83.3% | 4,000 | -2.4% | 0.00% | – |
| Q2 2016 | $18,000 | +12.5% | 4,097 | +2.4% | 0.00% | – |
| Q1 2016 | $16,000 | -42.9% | 4,000 | 0.0% | 0.00% | – |
| Q4 2015 | $28,000 | -41.7% | 4,000 | 0.0% | 0.00% | – |
| Q3 2015 | $48,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|